Table 3.
Characteristiscs | Generic Core Scale | p-value | Cancer Module |
p-value | Multidimensional Fatigue Module | p-value | |||
---|---|---|---|---|---|---|---|---|---|
Argentina mean (sd) |
Sweden mean (sd) |
Argentina mean (sd) |
Sweden mean (sd) |
Argentina mean (sd) |
Sweden mean (sd) |
||||
Gender | |||||||||
Female | 55.5(16.6) | 59.2(19.0) | 0.72 | 68.6(12.2) | 67.7(15.8) | 0.88 | 72.8(22.4) | 68.2(15.5) | 0.23 |
Male | 66.9(16.4) | 58.8(16.6) | 0.18 | 66.6(14.2) | 63.1(18.5) | 0.59 | 77.9(17.7) | 58.4(17.3) | 0.002 |
Age groups | |||||||||
2 to 4 years | 69.6(21.7) | 65.0(19.6) | 0.51 | 67.9(13.6) | 72.3(17.4) | 0.60 | 77.3(26.5) | 68.1(17.6) | 0.14 |
5 to 12 years | 58.1(15.4) | 62.2(17.1) | 0.52 | 66.9(13.6) | 67.9(14.0) | 0.97 | 78.6(19.1) | 70.3(12.5) | 0.15 |
13 to 18 years | 60.6(12.6) | 49.5(12.4) | 0.09 | 67.3(14.1) | 55.2(17.0) | 0.18 | 72.4(10.7) | 49.6(13.6) | p < 0.0001 |
Diagnostic groups | |||||||||
Leukaemia | 63.8(16.8) | 66.6(19.8) | 0.69 | 69.3(13.9) | 75.9(15.9) | 0.22 | 73.8(14.8) | 77.1(18.9) | 0.33 |
Solid tumours | 63.1(22.6) | 52.3(14.1) | 0.57 | 62.3(9.3) | 56.1(15.8) | 0.46 | 83.1(7.0) | 52.2(15.2) | 0.003 |
CNS tumours | 54.7(10.4) | 55.6(12.7) | 1.00 | 63.7(16.6) | 59.9(11.7) | 0.79 | 54.6(16.1) | 59.7(9.4) | 1.00 |
Treatment modality | |||||||||
Chemotherapy | 65.8(17.1) | 62.6(18.3) | 0.60 | 69.0(13.1) | 70.4(18.6) | 0.53 | 79.3(18.5) | 65.7(18.2) | 0.009 |
Combined therapy | 47.4(4.2) | 53.5(15.1) | 0.23 | 59.3(12.4) | 57.3(11.1) | 0.83 | 59.7(15.7) | 58.7(14.5) | 0.76 |
Note: Scores range from 0 to 100; higher scores represent a better HRQOL. Significant differences are highlighted in bold type. sd standard deviation